http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101893947-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-998 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0645 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-164 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0786 |
| filingDate | 2016-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101893947-B1 |
| titleOfInvention | Active compositions of macrophage containing the Rv2882c protein |
| abstract | The present invention relates to an activated composition of macrophages containing Rv2882c protein of Mycobacterium tuberculosis as an active ingredient. Further, the present invention relates to a method for treating macrophages by treating Rv2882c protein of Mycobacterium tuberculosis with inactivated macrophages. The present invention also relates to a composition for enhancing immunity comprising the above-mentioned composition for activating macrophages. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102405798-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200065257-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210157659-A |
| priorityDate | 2016-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 480.